Trial Profile
Effectiveness and safety of ledipasvir and sofosbuvir for patients infected with HCV genotype 1 in clinical practices
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Sep 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 16 Sep 2017 Status changed to completed.
- 26 Sep 2016 New trial record